Intravenous Oxytocin Use to Decrease Blood Loss during Scheduled Cesarean Delivery: A Randomized Double-Blinded...

Area of Science:

• Obstetrics and Gynecology
• Pharmacology
• Anesthesiology

Background:

• Postpartum hemorrhage is a significant risk during cesarean delivery.
• Oxytocin is commonly used to prevent excessive blood loss.
• Determining the optimal oxytocin dosage is crucial for patient safety and effective management.

Purpose of the Study:

• To investigate the impact of varying intravenous oxytocin doses on blood loss during cesarean delivery.
• To identify the most effective oxytocin regimen for minimizing intraoperative and postoperative blood loss.

Main Methods:

• A randomized controlled trial involving 189 low-risk women undergoing scheduled cesarean delivery.
• Participants were assigned to receive 20, 30, or 40 units of oxytocin in 500 mL of lactated Ringer solution.
• Hemoglobin change from pre- to post-cesarean delivery was the primary outcome measure.

Main Results:

• No statistically significant differences in hemoglobin drop or calculated blood loss were observed among the three oxytocin dosage groups.
• The incidence of intraoperative hypotension and postoperative blood pressure changes was similar across all groups.
• Average blood loss ranged from approximately 794 mL to 820 mL, with no significant variation.

Conclusions:

• Intravenous oxytocin doses of 20, 30, and 40 units did not result in significantly different blood loss during cesarean delivery.
• The lowest dose of 20 units of oxytocin administered in 500 mL of lactated Ringer solution appears to be an appropriate and effective regimen.
• Further research may explore cost-effectiveness and specific patient populations.